# Lacripep for Corneal Wound Healing Study

> **NCT06854393** · PHASE2 · RECRUITING · sponsor: **Henry M. Jackson Foundation for the Advancement of Military Medicine** · enrollment: 88 (estimated)

## Conditions studied

- Corneal Epithelial Wound Healing

## Interventions

- **DRUG:** 0.00025% Lacripep ophthalmic solution and Placebo

## Key facts

- **NCT ID:** NCT06854393
- **Lead sponsor:** Henry M. Jackson Foundation for the Advancement of Military Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-23
- **Primary completion:** 2027-06
- **Final completion:** 2027-09
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-03-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06854393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06854393, "Lacripep for Corneal Wound Healing Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06854393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*